Treatment of Infectious Disease: Drugs and Drug Resistance

Johns Hopkins Public Health Preparedness Programs

CPHP Trainings

PERRC Projects

Trainer
Gary Ketner, PhD, Johns Hopkins School of Public Health

Description
In this presentation, Dr. Ketner examines the history of chemotherapy and how it applies to the topic of drug creation and drug resistance.

Contents

Please click the "Launch This Training" button to access the content listed below. These training materials are available to you free of charge; no payment is necessary.

Topic 1: Treatment of Infectious Disease: Drugs and Drug Resistance
Part 1: History and Principles of Chemotherapy
Part 2: Mechanisms of Selective Toxicity
Part 3: Drug Resistance in Public Health
Part 4: Sources and Consequences of Drug Resistance

Trainer
In his work with the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, Dr. Ketner works extensively on projects dealing with adenoviruses and live vector vaccine development. Work on a gene delivery project is aimed at the development of recombinant adenoviruses as vectors for live vaccines. Safe and effective live adenovirus vaccines exist, and modified versions of those vaccines may be able to confer immunity to other pathogens. The preliminary vaccine target is human papillomavirus, the etiologic agent of cervical cancer.